Last updated: February 23, 2024
Sponsor: Herlev Hospital
Overall Status: Completed
Phase
N/A
Condition
Cerebral Ischemia
Stroke
Treatment
N/AClinical Study ID
NCT05051111
21054586
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Clinical symptoms of acute stroke, verified by a neurologist with diagnosis of stroke (intracerebral haemorrhage, cerebral infarction, "stroke, not specified as haemorrhageor infarction" or transient ischemic attack (TIA)).
- Acute/subacute stroke or TIA verified on MRI-scan or CT-scan.
- Able to speak, read and understand Danish.
- Able to provide informed consent, including being awake, alert and oriented (personaldata, place, and time).
Exclusion
Exclusion Criteria:
- Aphasia that hinders responding to the PAS2.
- Cognitive deficits that hinder responding to the PAS2 (Mini-Mental StateExamination-score (MMSE) ≤ 23, diagnosis of dementia at hospital admission).
Study Design
Total Participants: 123
Study Start date:
September 23, 2021
Estimated Completion Date:
December 31, 2022
Study Description
Connect with a study center
Herlev Gentofte Hospital
Herlev, 2730
DenmarkSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.